It was later approved for patients with platelet disorders such as Glazmann thrombasthenia.Actually, it has been used off-label for the management of bleeding in pediatric patients.
Posteriormente fue aprobado para pacientes con trastornos plaquetarios como la trombastenia de Glazmann.